Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endoscopic optic canal decompression with or without HU-MSC transplantation for traumatic optic neuropathy
ChiCTR-TRC-14005093Phase 2Recruiting
- Sponsor
- Cell Biotherapy Center
- Start
- Sep 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of Human umbilical cord mesenchymal stem cells in traumatic optic neuropathy (TON) (2 arms), sponsored by Cell Biotherapy Center. Primary endpoints: Vision, Visual field and 1 more. Started Sep 2014; status: recruiting.
02
Drugs
Human umbilical cord mesenchymal stem cells
03
Conditions
traumatic optic neuropathy (TON)
Beyond the preview
Go deeper on ChiCTR-TRC-14005093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14005093.